CLSN with HCC Phase III Clinical Trial (Special Protocol Assessment Guidance).
GNBT with AE37 (Antigen express) Phase IIb and start new Phase III Clinical Trial (Special Protocol Assessment?) Primary survival data is spectacular (46%!)
Best regards.
Is my humble opinion. This is not a recommendation to buy or sell. Each person does with his money what he thinks fit.